Use of Touch and no Touch Guide-wire Techniques for Deep Biliary Cannulation: the TNT Study

Sponsor
Azienda Usl di Bologna (Other)
Overall Status
Completed
CT.gov ID
NCT01954602
Collaborator
Catania Hospital Gastroenterology (Other), Niguarda Hospital (Other)
206
1
2
21
9.8

Study Details

Study Description

Brief Summary

The specific goal of this study is to compare the deep biliary cannulation rate and complication rates associated with use of touch and no touch guide-wire biliary cannulation techniques.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Guide-wire cannulation
  • Procedure: Sphincterotome assisted guide-wire cannulation
N/A

Detailed Description

The most common technique used to achieve primary deep biliary cannulation is the standard contrast-assisted method, in which a catheter or sphincterotome is introduced into the papilla in the direction of the bile duct and a contrast medium injected to confirm that the duct has been cannulated.

The biliary guidewire cannulation technique consists of the introduction of a guide-wire into the bile duct instead of contrast injection as the first maneuver.

The benefit of this technique, compared with classic contrast cannulation, has been demonstrated in several studies which show similar results and have been analyzed in a recent meta-analysis, including 5 studies and 1762 patients, and demonstrating that the use of the guide-wire technique significantly improved the primary cannulation rate from 74.9% to 85.3%. More importantly, significantly reduced the incidence of PEP from 8.6% to 1.6%.

There are several variations of this technique; the tip of the sphincterotome is inserted initially a few millimeters through the papillary orifice and then introduce the guide-wire to the target ("touch technique"). Another variation is direct cannulation with the guide-wire hovering a few millimeters through the catheter or sphincterotome ("no touch technique").

To date, there are no randomized controlled trials comparing the two above described way to access to biliary duct regarding efficacy and rate of complications.

Study Design

Study Type:
Interventional
Actual Enrollment :
206 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
A Multicenter Randomized Trial Comparing the Use of Touch and no Touch Guide-wire Techniques for Deep Biliary Cannulation: the TNT Study
Actual Study Start Date :
Jul 1, 2013
Actual Primary Completion Date :
Mar 1, 2015
Actual Study Completion Date :
Apr 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Touch group

Sphincterotome assisted guide-wire cannulation

Procedure: Sphincterotome assisted guide-wire cannulation
Sphincterotome is inserted initially a few millimeters through the papillary orifice

Experimental: No touch group

Guide-wire cannulation

Procedure: Guide-wire cannulation
Direct guide-wire hovering a few millimeters through the catheter or sphincterotome

Outcome Measures

Primary Outcome Measures

  1. Cannulation success rate [No more than 5 minutes of biliary cannulation or 5 unintended pancreatic duct cannulation with the guidewire, with both techniques]

Secondary Outcome Measures

  1. Incidences of PEP [from the intervention until two days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 or older

  • Clinical symptoms, laboratory findings and radiological evidences of biliary disease

  • Willing and able to comply with the study procedures and provide written informed consent to participate in the study

Exclusion Criteria:
  • Age <18 yars

  • Patients with previous sphincterotomy

  • Patients with previous papillary endoscopic balloon dilation

  • Presence of a previously placed plastic or metal biliary stent

  • Presence of any esophageal or gastro/duodenal stent

  • Pancreatic or ampullary cancer, proven by imaging and/or cytology and/or histology, are excluded as PEP is very uncommon in these subgroups and tumour-related anatomical variation may alter cannulation technique (consider substratify results for this subgroup, but exclude if duodenal stenosis precludes an attempt on the papilla)

  • Patients with surgically altered anatomy (Bilroth II gastrectomy and Roux en Y anastomosis) are excluded as cannulation technique is fundamentally different from that in normal anatomy

  • Presence of a diverticular papilla

  • Presence of a duodenal stenosis

  • Presence of a pancreas divisum

  • Patients with contraindication to endoscopic procedures

  • Hemodinynamic instability, any acute illness or exacerbation of chronic illness, acute infections.

  • Platelet count less than 50,000/mm3 and INR no greater than 1.5 times upper limit of normal

  • Inability or refusal to give informed consent.

  • Refusal to provide consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Azienda Unità Sanitaria Locale Bologna Italy 40100

Sponsors and Collaborators

  • Azienda Usl di Bologna
  • Catania Hospital Gastroenterology
  • Niguarda Hospital

Investigators

  • Study Chair: Elio Jovine, MD, AUSL Bologna

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
CARLO DESCOVICH, Medical Doctor, Azienda Usl di Bologna
ClinicalTrials.gov Identifier:
NCT01954602
Other Study ID Numbers:
  • CE 13028 TNT study
First Posted:
Oct 7, 2013
Last Update Posted:
Mar 28, 2017
Last Verified:
Mar 1, 2017
Keywords provided by CARLO DESCOVICH, Medical Doctor, Azienda Usl di Bologna
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 28, 2017